Clopidogrel 75 Mg Pd 75 mg FC tablet.
PDF Leaflet Revision Date: 24 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of atherosclerotic events and management of acute coronary syndrome.
Dosage (summary)
75 mg once daily; 300 mg loading dose for acute coronary syndrome.
Onset of Action / Duration
Onset: 2 hours, Duration: 7-10 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation.
Key Drug Interactions
- Aspirin
- Warfarin
- NSAIDs
- SSRIs
- CYP2C19 inhibitors
Contraindications
- Hypersensitivity
- Active bleeding
- Severe liver impairment
- Thrombocytopenia
Common side effects
- Bleeding
- Bruising
- Abdominal pain
- Headache
Counselling Points
- Report unusual bleeding
- Inform healthcare providers before surgery
- Avoid double dosing
Serious warnings
- Thrombotic Thrombocytopenic Purpura (TTP)
- Increased bleeding risk
Important Disclaimer
The Clopidogrel 75 Mg Pd 75 mg FC tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
